{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:45Z","timestamp":1760775045367,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015787","name":"Jiangsu Province Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bmcl.2024.129678","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T11:41:38Z","timestamp":1708774898000},"page":"129678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis and initial evaluation of radioiodine-labelled deuterated tropane derivatives targeting dopamine transporter"],"prefix":"10.1016","volume":"102","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojiao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1920-9464","authenticated-orcid":false,"given":"Zhengping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129678_b0005","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/jcbfm.2014.63","article-title":"Radiosynthesis and validation of 18F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain","volume":"34","author":"Cumming","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.bmcl.2024.129678_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells8080872","article-title":"Molecular imaging of the dopamine Transporter","volume":"8","author":"Palermo","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bmcl.2024.129678_b0015","first-page":"1","article-title":"Overview of the structure and function of the dopamine transporter and its protein interactions","volume":"2023","author":"Nepal","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.bmcl.2024.129678_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms222011234","article-title":"Dopamine transporter imaging, current status of a potential biomarker: a comprehensive review","volume":"22","author":"Palermo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2024.129678_b0025","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bmcl.2024.129678_b0030","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2169\/internalmedicine.2489-18","article-title":"Dopamine transporter imaging in parkinson disease: progressive changes and therapeutic modification after anti-parkinsonian medications","volume":"58","author":"Ikeda","year":"2019","journal-title":"Internal Med"},{"key":"10.1016\/j.bmcl.2024.129678_b0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-3-642-42014-6_10","article-title":"PET and SPECT imaging of the central dopamine system in humans","author":"Booij","year":"2014","journal-title":"PET SPECT Neurobiol Syst"},{"key":"10.1016\/j.bmcl.2024.129678_b0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.15561","article-title":"Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool","volume":"164","author":"Nicastro","year":"2022","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmcl.2024.129678_b0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2967\/jnumed.114.148619","article-title":"Use of 11C-PE2I PET in differential diagnosis of Parkinsonian disorders","volume":"56","author":"Appel","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2024.129678_b0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11307-021-01603-2","article-title":"Synthesis and biological evaluation of [18F]FECNT-d4 as a novel PET agent for dopamine transporter Imaging.","volume":"23","author":"Cao","year":"2021","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.bmcl.2024.129678_b0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2191-219X-2-3","article-title":"18F]CFT synthesis and binding to monoamine transporters in rat[J","volume":"2","author":"Forsback","year":"2012","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.bmcl.2024.129678_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41181-020-00105-w","article-title":"Fully automated radiosynthesis of [18F]LBT999 on TRACERlab FXFN and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain","volume":"5","author":"Vala","year":"2020","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.bmcl.2024.129678_b0065","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1021\/acs.molpharmaceut.1c00172","article-title":"Synthesis and biological evaluation of 99mTc-labeled phenylpiperazine derivatives as selective Serotonin-7 receptor ligands for brain tumor imaging","volume":"18","author":"Saednia","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2024.129678_b0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/acs.molpharmaceut.1c00712","article-title":"Preparation and bioevaluation of 99mTc-labeled FAP inhibitors as tumor radiotracers to target the fibroblast activation protein","volume":"19","author":"Ruan","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2024.129678_b0075","doi-asserted-by":"crossref","first-page":"15960","DOI":"10.1021\/acs.jmedchem.0c01710","article-title":"Iodinated choline transport-targeted tracers","volume":"63","author":"Svec","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129678_b0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2967\/jnmt.112.111617","article-title":"A new era of clinical dopamine transporter imaging using 123I-FP-CIT","volume":"40","author":"Park","year":"2012","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.bmcl.2024.129678_b0085","first-page":"753","article-title":"Van royen. one-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson\u2019s disease by [123I]FPCIT SPECT","author":"Jan Booij","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2024.129678_b0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13139-011-0117-5","article-title":"Effect of animal condition and fluvoxamine on the result of [18F]N-3-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl) nortropane ([18F]FP-CIT) PET study in Mice","volume":"46","author":"Shin","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.bmcl.2024.129678_b0095","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s002590050346","article-title":"Iodine-123 labelled nor-\u03b2-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats","volume":"25","author":"Jan Booij","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.bmcl.2024.129678_b0100","first-page":"745","article-title":"Metabolism of 123I-FP-CIT in humans","volume":"36","author":"Tanaka","year":"1999","journal-title":"Kaku Igaku"},{"issue":"47","key":"10.1016\/j.bmcl.2024.129678_b0105","first-page":"520","article-title":"PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements","volume":"3","author":"Sami","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2024.129678_b0110","first-page":"596","article-title":"In vitro and in vivo characterisation of nor-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain","volume":"24","author":"Kim","year":"1997","journal-title":"Original Article"},{"key":"10.1016\/j.bmcl.2024.129678_b0115","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/jm4007998","article-title":"Using deuterium in drug discovery: leaving the label in the drug","volume":"57","author":"Gant","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129678_b0120","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1039\/D1CS00907A","article-title":"Radical deuteration","volume":"51","author":"Li","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmcl.2024.129678_b0125","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1039\/D0CS01496F","article-title":"C-H deuteration of organic compounds and potential drug candidates","volume":"51","author":"Prakash","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmcl.2024.129678_b0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0009-2797(98)00097-0","article-title":"Deuterium isotope effects on noncovalent interactions between molecules","volume":"1999","author":"Wade","year":"1999","journal-title":"Chemico-Biol Interact"},{"key":"10.1016\/j.bmcl.2024.129678_b0135","doi-asserted-by":"crossref","unstructured":"Citrome L. Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication\u2014What is the number needed to treat, number needed to harm and likelihood to be helped or harmed. Int J Clin Pract, 2017, 13030: 1-17. https:\/\/doi.org\/10.1111\/ijcp.13030.","DOI":"10.1111\/ijcp.13030"},{"key":"10.1016\/j.bmcl.2024.129678_b0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nucmedbio.2021.03.011","article-title":"Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals","volume":"96","author":"Klenner","year":"2021","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmcl.2024.129678_b0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2967\/jnumed.115.161083","article-title":"In vivo and in vitro characterization of a novel MAO-B inhibitor radioligand, 18F-labeled deuterated Fluorodeprenyl","volume":"57","author":"Nag","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2024.129678_b0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nucmedbio.2020.03.003","article-title":"Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of \u03b2-amyloid in the brain","volume":"2021","author":"Zha","year":"2021","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmcl.2024.129678_b0155","first-page":"1","article-title":"Deuterated [18F]fluoroethyl tropane analogs as dopamine transporter probes: synthesis and biological evaluation","volume":"118","author":"Li","year":"2023","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmcl.2024.129678_b0160","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/jm00114a027","article-title":"[123I]-2\u03b2-carbomethoxy-3\u03b2-(4-iodophenyl)tropane-high-affinity SPECT","volume":"34","author":"Neumeyer","year":"1991","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129678_b0165","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/acs.molpharmaceut.2c00176","article-title":"Novel 18F-labeled PET tracers specific to aromatase: design, synthesis, and biological evaluation","volume":"19","author":"Zheng","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2024.129678_b0170","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/syn.21838","article-title":"Characterization of [123I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitroautoradiography","volume":"69","author":"Geisler","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.bmcl.2024.129678_b0175","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem Pharmacol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:50:23Z","timestamp":1760773823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"alternative-id":["S0960894X24000805"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129678","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and initial evaluation of radioiodine-labelled deuterated tropane derivatives targeting dopamine transporter","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129678"}}